Membio
Scalable single-use bioreactors.
- Headquarters
- Mississauga
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- membio.ca
- Total Funding
- $40K
About
Membio developed proprietary single-use bioreactor technology purpose-built to enable cost-effective and scalable manufacturing of cells for cell therapy and gene therapy applications. Founded in 2018 in Mississauga, Ontario, the company focused on bioprocess development and R&D. In late 2023, Membio's bioreactor technology was acquired by ABEC Inc.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account